Cirrus Logic (NASDAQ:CRUS) used its fiscal third-quarter 2026 earnings Q&A session to highlight stronger-than-expected ...
Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results